Role of the Immune System in Preventing Laryngeal Cancer
Recruiting
Observational Study
Head & Neck Cancer
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 99
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3 (estimated)
- Sponsor
- European Institute of Oncology · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Laryngeal dysplasia and progression to carcinoma: investigating genetic and immune alterations predictive of malignant transformation
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Histopathological diagnosis of laryngeal dysplasia.
* Age \>18 years and informed consent.
Exclusion Criteria:
* Prior surgical, radiotherapeutic, or oncologic treatments for head and neck regions.
* Congenital or acquired immunodeficiency disorders.
* Synchronous malignanci…
Contacts